Clinical Trial Update: Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo [Phase 3]

View source ↗

Summary

Phase 3 comparative study evaluating oral eletriptan and oral sumatriptan against placebo for migraine with or without aura; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine with or Without Aura

Drugs mentioned

• Eletriptan (eletriptan)
• Sumatriptan (Sumatriptan)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Migraine With or Without Aura | Phase 3 | Status: COMPLETED